305 573

Cited 14 times in

Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.

Authors
 Yeon Jung Lee  ;  Soo Hyun Oh  ;  Chanmin Park  ;  Minha Hong  ;  Ah Rah Lee  ;  Hee Jeong Yoo  ;  Chan Young Shin  ;  Keun Ah Cheon  ;  Geon Ho Bahn 
Citation
 CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, Vol.12(1) : 19-30, 2014 
Journal Title
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
ISSN
 1738-1088 
Issue Date
2014
Keywords
Child development disorders, pervasive ; Drug therapy ; Etiology
Abstract
In clinical practice, pharmacological treatment is mostly focused on behavioral symptoms in everyday life. Nevertheless, persistent effort continues to develop medication for causal treatment. Recent changes in diagnostic criteria from Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) to DSM-5 would affect not only diagnosing approaches, but also therapeutic approaches. Because previous pervasive developmental disorders have been integrated into a single entity, the autism spectrum disorder (ASD), we have to prepare for what medications are valuable for the ASD. In this article, we reviewed the following etiological treatment: acetylcholine and glutamate related medicine; amino acid medicine such as secretin, endogenous opioid, and oxytocin; complementary and alternative medicine such as chelating agents, vitamins, and omega-3; promising drugs related to the scope of pharmacogenetics currently under study.
Files in This Item:
T201405665.pdf Download
DOI
10.9758/cpn.2014.12.1.19
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Cheon, Keun Ah(천근아) ORCID logo https://orcid.org/0000-0001-7113-9286
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138812
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links